B+
Bull case
25%
Probability
Target price
$44.00
+33.2% vs current
G
GenpactDNYSE / Commercial & Professional Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$36.00
+9.0% vs current
B-
Bear case
25%
Probability
Target price
$29.00
-12.2% vs current
AI sentiment snapshot
Latest data as of 2026-05-09
Recent news sentiment (30D)
+0.1
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+58.7
Score
AI commentary
The earnings release was fundamentally positive, but the market reaction was not: the stock closed at $34.48 on May 7, 2026 and the latest trade on May 8, 2026 was $32.56, a decline of about 5.5% from the prior close. That pattern fits a mixed read where investors acknowledged the Q1 beat and ATS momentum but wanted a stronger forward revision signal. News flow is currently earnings-driven rather than broad, and the lack of clearly documented post-print analyst target or estimate changes at this T+3 checkpoint keeps conviction moderate rather than high.
RankAlpha Sentiment Codex - 2026-05-09
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-07eventQ1 print showed strong ATS-led growth but mixed market receptionMedium impact
Genpact's May 7 earnings release reported Q1 net revenue of $1.296 billion (+6.7% y/y), ATS revenue of $345 million (+24.3% y/y, 27% of revenue), diluted EPS of $0.86 and adjusted EPS of $0.98, while management guided to Q2 revenue of $1.324-$1.336 billion and full-year 2026 revenue growth of at least 7% with ATS growth of at least 20% [#8-K-2026-05-07]. The next-day share decline suggests investors want cleaner proof that the AI/agentic mix shift can translate into sustained upside, not just a solid quarter.
2026-08-06catalystQ2 execution against guide is the key near-term checkpointHigh impact
Management's Q2 outlook calls for roughly 5.5%-6.5% reported growth, gross margin near 36.4%, adjusted operating margin near 17.4%, and adjusted EPS of $0.96-$0.97 [#8-K-2026-05-07]. With delayed post-print analyst revision evidence still thin, the stock likely needs a clearer beat-versus-guide setup by the next report to repair sentiment after the initial negative reaction.
2026-12-31catalystATS mix shift and margin expansion remain the core structural thesisHigh impact
The 10-Q shows ATS revenue rose 24.3% while Core Business Services grew 1.4%, and management cited demand for data and AI, agentic solutions, advisory work, technology-related services, and ramp-ups of recently signed deals [#10-Q-2026-05-08]. If Genpact can keep shifting mix toward higher-value ATS while extending margin gains, the current depressed multiple can rerate over a multi-quarter horizon.
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-09 • Updated nightlySource: Internal modelMethodology